Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection

Peter Benn's Biography



Peter Benn, Professor Emeritus, Department of Genetics and Genome Sciences, University of Connecticut Health Center

Peter Benn completed his undergraduate degree at the University of St Andrews, Scotland, received a PhD from the University of Birmingham, England, and post-doctoral training at the University of Pennsylvania. He also holds a DSc degree from the University of St Andrews. For the past 25 years he has been a faculty member at the University of Connecticut Health Center and is currently Professor Emeritus in the Department of Genetics and Genome Sciences. Clinical responsibilities have included oversight of the cytogenetics and prenatal screening laboratories. His research interests have focused on prenatal testing and diagnosis, most recently involving the introduction of non-invasive prenatal testing. Dr Benn chaired the International Society for Prenatal Diagnosis (ISPD)’s Special Interest Group (SIG) for Prenatal Screening. He has also chaired ISPD’s Committee for Chromosome Abnormality Screening which developed Position Statements for non-invasive prenatal screening.

Peter  Benn Image

Non-Invasive Prenatal Screening for Genetic Disorders Using Cell-Free DNA in Maternal Plasma

Thursday, 29 March 2018 at 14:30

Add to Calendar ▼2018-03-29 14:30:002018-03-29 15:30:00Europe/LondonNon-Invasive Prenatal Screening for Genetic Disorders Using Cell-Free DNA in Maternal PlasmaSELECTBIOenquiries@selectbiosciences.com

Methods to quantify fetal DNA copy number in maternal plasma has revolutionized prenatal screening and diagnosis of Down syndrome, other autosomal trisomies, sex chromosome abnormalities, and some microdeletion syndromes.  This testing provides more accurate and screening than was previously possible and has thereby drastically reduced the number of chorionic villus biopsies and amniocenteses that are performed to confirm screening results.  This non-invasive prenatal testing is being extended to include additional genetic conditions including single gene disorders.  This talk will discuss the current status of this screening and comment on future prospects.


Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonCirculating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection SELECTBIOenquiries@selectbiosciences.com